Trials / Conditions / Prostate Cancer Metastatic Castration-Resistant
Prostate Cancer Metastatic Castration-Resistant
5 registered clinical trials studyying Prostate Cancer Metastatic Castration-Resistant — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | External Beam and Radioligand Radiotherapy for mCRPC NCT07354594 | Centre hospitalier de l'Université de Montréal (CHUM) | Phase 2 |
| Recruiting | Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cance NCT07179783 | Tianjin Medical University Second Hospital | Phase 2 |
| Recruiting | Liquid Biopsy Under PSMA Radioligand Therapy NCT07118436 | Wuerzburg University Hospital | — |
| Active Not Recruiting | Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration- NCT03012321 | Northwestern University | Phase 2 |
| Terminated | Multicenter Study Comparing Taxotere Plus Curcumin Versus Taxotere Plus Placebo Combination in First-line Trea NCT02095717 | Centre Jean Perrin | Phase 2 |